Clinical Trials & Research

A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies. Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegenerative condition
0 Comments
New research has revealed that targeted cognitive training can successfully reduce cognitive impairment in treatment-resistant schizophrenia. Altering certain neural pathways may improve cognitive ability in people with treatment-resistant schizophrenia. Schizophrenia is one of the 15 leading causes of disability globally. In the United States, this condition affects more than 3 million people. Symptoms of schizophrenia
0 Comments
For the first time in decades, researchers have identifed a new medication that can successfully treat major depression. An existing oral drug may relieve major depression. Depression affects about 300 million people across the globe, making the condition the “leading cause of ill health and disability worldwide,” according to the World Health Organization (WHO). In
0 Comments
A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. A new form of radiotherapy may significantly improve survival for people with prostate cancer. The National Cancer Institute (NCI) estimate that prostate cancer affects over 160,000 people in
0 Comments
Researchers created a database for the daily circadian rhythms of genetic activity. The findings may help physicians time the delivery of drugs in accordance with a person’s body clock, boosting treatment for cardiovascular disease and other conditions. Our body clock can influence how effective drugs are — especially for treating cardiovascular problems. Our circadian rhythm,
0 Comments
A recent clinical trial could change the face of therapy for a very aggressive and stubborn form of breast cancer: triple-negative. A combination of chemotherapy and immunotherapy boosts survival rates, the scientists found. A new clinical trial confirms that immunotherapy can help prolong the life of people with triple-negative breast cancer. Triple-negative breast cancer is
0 Comments